Lv11
40 积分 2024-10-29 加入
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
7小时前
已完结
Searching for the minimum required dose of daratumumab to induce effective plasma cell depletion in antibody-mediated rejection of the kidney graft: a case report
7小时前
已完结
Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantation
7小时前
已完结
Daratumumab Monotherapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Efficacy, NK Cell Dynamics, and Long-Term Outcomes
7小时前
求助中
CD38 inhibition by felzartamab promising for resolution of antibody-mediated rejection following kidney allografts
7小时前
求助中
Desensitization in Kidney Allograft Using Daratumumab
7小时前
求助中
皖公网安备34019202002308
